Logo image of ARC.CA

ARCPOINT INC (ARC.CA) Stock Fundamental Analysis

Canada - TSX-V:ARC - CA03966D1078 - Common Stock

0.035 CAD
0 (0%)
Last: 9/23/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ARC. ARC was compared to 15 industry peers in the Health Care Providers & Services industry. ARC has a bad profitability rating. Also its financial health evaluation is rather negative. ARC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ARC was profitable.
In the past year ARC has reported a negative cash flow from operations.
ARC.CA Yearly Net Income VS EBIT VS OCF VS FCFARC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of 69.77%, ARC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 69.77%
ROE N/A
ROIC N/A
ROA(3y)-46.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARC.CA Yearly ROA, ROE, ROICARC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 400 600 800 1K

1.3 Margins

Looking at the Profit Margin, with a value of 53.94%, ARC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of ARC has declined.
ARC has a better Gross Margin (69.28%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of ARC has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 53.94%
GM 69.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.24%
PM growth 5YN/A
GM growth 3Y-2.9%
GM growth 5YN/A
ARC.CA Yearly Profit, Operating, Gross MarginsARC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

ARC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARC has been increased compared to 1 year ago.
The debt/assets ratio for ARC is higher compared to a year ago.
ARC.CA Yearly Shares OutstandingARC.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
ARC.CA Yearly Total Debt VS Total AssetsARC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

ARC has an Altman-Z score of -13.23. This is a bad value and indicates that ARC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ARC (-13.23) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.23
ROIC/WACCN/A
WACC5.45%
ARC.CA Yearly LT Debt VS Equity VS FCFARC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 0.08 indicates that ARC may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.08, ARC is doing worse than 80.00% of the companies in the same industry.
ARC has a Quick Ratio of 0.08. This is a bad value and indicates that ARC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.08, ARC is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
ARC.CA Yearly Current Assets VS Current LiabilitesARC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 112.99% over the past year.
ARC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -92.96% yearly.
ARC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.43%.
ARC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -34.00% yearly.
EPS 1Y (TTM)112.99%
EPS 3Y-92.96%
EPS 5YN/A
EPS Q2Q%66.46%
Revenue 1Y (TTM)-17.43%
Revenue growth 3Y-34%
Revenue growth 5YN/A
Sales Q2Q%-89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARC.CA Yearly Revenue VS EstimatesARC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.17, the valuation of ARC can be described as very cheap.
100.00% of the companies in the same industry are more expensive than ARC, based on the Price/Earnings ratio.
ARC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.29.
Industry RankSector Rank
PE 1.17
Fwd PE N/A
ARC.CA Price Earnings VS Forward Price EarningsARC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARC.CA Per share dataARC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ARC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARCPOINT INC

TSX-V:ARC (9/23/2025, 7:00:00 PM)

0.035

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners14.01%
Ins Owner ChangeN/A
Market Cap4.49M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.17
Fwd PE N/A
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.03
EY85.71%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.04
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 69.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 53.94%
GM 69.28%
FCFM N/A
ROA(3y)-46.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.24%
PM growth 5YN/A
GM growth 3Y-2.9%
GM growth 5YN/A
F-Score5
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -13.23
F-Score5
WACC5.45%
ROIC/WACCN/A
Cap/Depr(3y)199.81%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.36%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.99%
EPS 3Y-92.96%
EPS 5YN/A
EPS Q2Q%66.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.43%
Revenue growth 3Y-34%
Revenue growth 5YN/A
Sales Q2Q%-89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.14%
OCF growth 3YN/A
OCF growth 5YN/A